Together, they examine the real-world use of antiseizure medication prophylaxis in patients with acute brain injury, including ischemic stroke, hemorrhagic stroke and traumatic brain injury. Dr. Dang highlights variability in current practice, key factors influencing prophylaxis decisions and the balance between seizure prevention and medication-related risks. She also reviews the study's limitations and underscores the ongoing importance of risk stratification in guiding patient care.
The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.
Podden och tillhörande omslagsbild på den här sidan tillhör
Neurocritical Care Society. Innehållet i podden är skapat av Neurocritical Care Society och inte av,
eller tillsammans med, Poddtoppen.